Article summary
A recently developed psychedelic compound promotes brain plasticity and reduces anxiety in mice without triggering gastrointestinal distress. The findings provide a chemical blueprint for designing safer, more tolerable psychiatric treatments.
Continue to the original publication for the complete article.